SMOFKABIVEN émuls perf 1970ml sach 4 pce
7680606890064
CH-60689
B05BA10
07.01.2.
1 / 3
google
Details
- Product number
- 6068903
- CPT
- -
- Packaging group
- 4 x 1970
- Unit
- ml
- Composition
- I) Glucoselösung 42 %: glucosum 250 g ut glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 595 ml. II) Aminosäurenlösung mit Elektrolyte: alaninum 14 g, argininum 12 g, glycinum 11 g, histidinum 3 g, isoleucinum 5 g, leucinum 7.4 g, lysinum anhydricum 6.6 g ut lysini acetas, methioninum 4.3 g, phenylalaninum 5.1 g, prolinum 11.2 g, serinum 6.5 g, taurinum 1 g, threoninum 4.4 g, tryptophanum 2 g, tyrosinum 400 mg, valinum 6.2 g, calcii chloridum anhydricum 560 mg ut calcii chloridum dihydricum, natrii glycerophosphas 4.2 g, magnesii sulfas anhydricus 1.2 g ut magnesii sulfas heptahydricus, kalii chloridum 4.5 g, natrii acetas 3.4 g ut natrii acetas trihydricus, zinci sulfas anhydricus 13 mg ut zinci sulfas heptahydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 1000 ml. III) Fettemulsion: sojae oleum raffinatum 22.5 g, triglycerida media 22.5 g, olivae oleum raffinatum 18.8 g, piscis oleum 11.3 g, int-rac-alpha-tocopherolum, phospholipida ex ovo purificata, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile q.s. ad emulsionem pro 375 ml. . I) et II) et III) corresp.: aminoacida 100 g, nitrogenia 16 g, carbohydrata 250 g, materia crassa 75 g, natrium 80 mmol, kalium 60 mmol, magnesium 10 mmol, calcium 5 mmol, phosphas 25 mmol, zincum 0.08 mmol, sulfas 10 mmol, chloridum 70 mmol, acetas 209 mmol, in emulsione recenter mixta 1970 ml. Corresp. 9200 kJ pro 1970 ml.
Articles (1)
SmofKabiven, Infusionsemulsion 1970 ml
Infusionsemulsion
4 x 1970
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
II
|
14.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
22.5 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
100.0 G | Substance | Wirkstoff (Principe actif) |
|
I
|
250.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
12.0 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | WIZUS |
|
III
|
22.5 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
16.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
250.0 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
11.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
18.8 G | Substance | Wirkstoff (Principe actif) |
|
III
|
11.3 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
3.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
75.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
80.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
5.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
60.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
7.4 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
10.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
6.6 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
123C
|
5.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
25.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
4.3 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
123C
|
0.08 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
5.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
11.2 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
10.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
6.5 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
70.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
123C
|
209.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
1.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
4.4 G | Substance | Wirkstoff (Principe actif) |
|
II
|
2.0 G | Substance | Wirkstoff (Principe actif) |
|
II
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
6.2 G | Substance | Wirkstoff (Principe actif) |
|
II
|
560.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
4.2 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.2 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
4.5 G | Substance | Wirkstoff (Principe actif) |
|
II
|
3.4 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
13.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 60689
- Drug name
- SmofKabiven, Infusionsemulsion
- Galenic form
- EMUI
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/01/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SMOFKABIVEN émuls perf 1970ml sach 4 pce
- Description (DE)
- SMOFKABIVEN Inf Emuls 1970ml Btl 4 Stk
- Market launch
- 26/01/2011
- Narcotic (BTM)
- No